A5085154416- Cardiac Valve Diseases and Treatments
- Infective Endocarditis Diagnosis and Management
- Coronary Interventions and Diagnostics
- Antiplatelet Therapy and Cardiovascular Diseases
- Aortic Disease and Treatment Approaches
- Acute Myocardial Infarction Research
- Smoking Behavior and Cessation
Chiang Mai University
2022-2024
Electronic cigarettes (e-cigarettes) use is trending in Thailand. are banned and illegally imported. This study aimed to investigate the behaviour, rationale, satisfaction of e-cigarettes users compared them between males females. A cross-sectional was conducted involving 1050 participants using from December 2019 February 2020. The were recruited by an online questionnaire posted on social media. current aged 18 years older. Of participants, 936 male (89.1%). average age 31.2 ± 8.4 years....
From the restriction of access to primary percutaneous coronary intervention, about 46% patients with ST-elevation acute syndrome (STE-ACS) received fibrinolytic therapy as a reperfusion strategy; streptokinase is frequently used in Thailand. Despite guidelines recommending potent P2Y12 inhibitors among these patients, data are limited, especially STE-ACS post therapy. The study was proposed describe factors for selection and evaluate outcomes pharmacoinvasively treated receiving ticagrelor...
The patterns of dual antiplatelet therapy (DAPT) use and the associated clinical outcomes in current practice remain limited. This study evaluates DAPT regimen among acute coronary syndrome (ACS) patients undergoing percutaneous intervention (PCI). multicenter retrospective cohort included ACS treated with PCI from January 2017 to February 2022 at five tertiary hospitals Thailand. was categorized as nonpotent (NP-DAPT) or potent (P-DAPT). We described trends, major adverse cardiovascular...
Background: Transcatheter aortic valve implantation (TAVI) has been shown to be effective in treating patients with severe symptomatic AS who are high-risk population for conventional surgical replacement (SAVR). This study aimed evaluate the cost–utility of TAVI compared SAVR stenosis high risk Thailand. Methods: Lifetime costs and quality-adjusted life years (QALYs) from societal healthcare perspectives were estimated using a two-part constructed model. The consisted 80-year-old risk....
Transcatheter Aortic Valve Implantation (TAVI) has been shown to provide comparable survival benefit and improvement in quality of life surgical aortic valve replacement (SAVR) for treating patients with severe stenosis (AS) at intermediate risk. This study aimed evaluate the cost-utility TAVI compared SAVR risk Thailand.A two-part constructed model was used analyze lifetime costs quality-adjusted life-years (QALYs) from societal healthcare perspectives. The cohort comprised AS an average...